Cargando…
Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity
Tumor vasculature abnormality creates a microenvironment that is not suitable for anti-tumor immune response and thereby induces resistance to immunotherapy. Remodeling of dysfunctional tumor blood vessels by anti-angiogenic approaches, known as vascular normalization, reshapes the tumor microenviro...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002465/ https://www.ncbi.nlm.nih.gov/pubmed/36901858 http://dx.doi.org/10.3390/ijms24054422 |